Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Transit bipartition using a metallic anastomotic clip and circular fundocorporeal gastroplication

Official title: The Laparoscopic Transit Bipartition Without Gastrectomy With Use of Metallic Anastomosis Clip (MAC) and Circular Fundocorporeal Gastroplication for Treating Type 2 Diabetes Mellitus and Obesity

Run by The Society of Bariatric and Metabolic Surgeons of Kazakhstan · NCT07495020 · Data updated 2026-11-12

This trial tries a new metallic anastomotic clip to create a second stomach-to-ileum pathway to help adults with type 2 diabetes and BMI 25–34.9 improve blood sugar control.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment90 (estimated)
SponsorThe Society of Bariatric and Metabolic Surgeons of Kazakhstan
Academic / other
Locations1 site (Astana)
StatusRecruiting
StartedApril 30, 2026
Main results expectedDecember 31, 2027
Study endsMay 30, 2028
Registry record updatedMay 7, 2026
Trial IDNCT07495020 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with clinically diagnosed type 2 diabetes and BMI between 25 and 34.9 kg/m² who are not insulin dependent and are willing to undergo laparoscopic surgery are ideal candidates.

Probably not a fit

People with insulin‑dependent diabetes, prior stomach surgery, BMI outside 25–34.9 kg/m², severe psychiatric illness, or who cannot consent are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized controlled trial comparing three laparoscopic transit bipartition approaches that use a novel Metallic Anastomotic Clip (MAC) to form gastro‑ileal and entero‑enteric anastomoses. The procedure creates an additional food pathway while preserving normal duodenal digestion to stimulate GLP‑1 secretion and improve glucose metabolism without major malabsorption. One arm includes circular fundocorporeal gastroplication, another pairs the bypass with a sleeve gastrectomy, and a third uses the MAC without gastrectomy. The trial builds on a small pilot of 10 patients that showed technical feasibility and safety of the device.

Why it matters

Potential benefit: If successful, the device and procedure could offer durable blood sugar improvement for adults with type 2 diabetes who have overweight or Class I obesity but do not meet current BMI thresholds for bariatric surgery.

How similar studies have gone: Bariatric and metabolic surgical approaches, including transit bipartition concepts, have improved T2DM outcomes in prior work, and a small 10‑patient pilot with the MAC showed technical feasibility though larger randomized data are not yet available.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of Type 2 Diabetes Mellitus
* BMI 25-35 kg/m2

Exclusion Criteria:

* Insulin dependent diabetes
* BMI \<25 and \>35 kg/m2
* History of surgery on the stomach
* Less than 18 or more than 65 years of age
* Psychiatric illness
* Patients unwilling or unable to provide informed consent

Where it's running

  • Oral Ospanov
    Astana, Kazakhstan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.